API holdings is the holding entity for the PharmEasy group and is India's leading digital healthcare platform. Company owns the PharmEasy brand which is a healthcare super app for consumers providing online pharmacy, OTC, teleconsultations, diagnostics services; D2C capabilities for offline pharmacies. Launched in 2015, PharmEasy is India's leading and most trusted online health aggregator in the country.

PharmEasy sells medicines and healthcare products, aids in connecting with local pharmacy stores and diagnostic centers to fulfil extensive medical needs, thereby enabling patients to receive healthcare services that are easily available, affordable, and accessible.

It is a Developer of online drug delivery platform designed to improve the supply chain of pharmaceuticals by completely digitizing the process.

PharmEasy parent API Holdings delayed its IPO plan for the time being. Instead, the company is trying to raise $200 million through private placements.

PharmEasy parent API Holdings delayed its IPO plan for the time being. Instead, the company is trying to raise $200 million through private placements.



image images




Siddharth Shah

Co-Founder, Managing Director, and Chief Executive Officer

Dharmil Sheth

Co-Founder and Whole-time Director

Harsh Parekh

Co-Founder and Whole-time Director

Schedule a meeting with the Private Equity Experts to understand more about Unlisted Shares & Stock Investments

Schedule Now


Approximate Valuation

Rs 24,100 crores

Face value

Rs 1 per share


This article is prepared on July 16, 2022. The views expressed herein are based on the facts and assumptions indicated in the document. All investment/financial opinions and/or views expressed herein are the personal views of the author. All the information contained herein is to be construed as indicative data which has to be corelated with actual market and economic conditions. It is very important for investors to do their own analysis before making any investment. The investor should take independent financial advice or independently research and verify, any information herein. The information contained in the report is not intended as, and shall not be understood or construed as, financial advice. Unintended and misprints may occur despite best efforts to ensure that all information is accurate and up to date.

Please remember at all times that

1. Investment in unlisted securities is subject to market risks.

2. Unlisted securities do not offer an easy exit route, such as selling on stock exchange, as in the case of listed securities.

3. Any future gains or losses indicated herein are projections, based on our understanding of the market and macro-economic situation as well as our understanding of the enterprise issuing the unlisted securities, as on the date of this communication. Future course of events may change the projections. We do not assume responsibility to update this report based on such changes.

4. We do not guarantee any profits, losses or rate of return.

Buy or Sell PharmEasy Unlisted Shares

For any queries, reach out to: unlisted@rurashfin.com or Call: +91 224157 1111